Company Overview

BOLT BIOTHERAPEUTICS, INC.

BOLT
Annual
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
8M
2025 FY
Net Income
-33M
2025 FY
Shares Outstanding
2M
2025 FY
EPS
-17.85USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1641281
Exchange
Nasdaq
Location
US